Posts Tagged "eczema drugs"

Tougher warning for eczema drugs?

Posted on Mar 27, 2010 in Uncategorized

FDA: Dozens of new reports of cancer, infection in children WASHINGTON – Novartis AG and Astellas Pharma eczema drugs may need their warning labels expanded after dozens of new reported cases of cancer and infection in children, U.S. Food and Drug Administration staff said in documents released on Thursday. Agency scientists said 46 cancer cases and 71 infection cases have been reported in patients aged 16 and younger from 2004 to 2008 with Novartis’ Elidel and Astellas’ Protopic. Both drugs — also known as pimecrolimus and tacrolimus respectively — already carry strong...

Read More